Shares of Phreesia, Inc. (NYSE:PHR – Get Rating) traded down 5.3% on Friday after Royal Bank of Canada lowered their price target on the stock from $51.00 to $29.00. Royal Bank of Canada currently has a sector perform rating on the stock. Phreesia traded as low as $27.45 and last traded at $27.45. 3,400 shares were traded during mid-day trading, a decline of 99% from the average session volume of 625,327 shares. The stock had previously closed at $28.99.
A number of other equities analysts have also weighed in on PHR. JMP Securities decreased their target price on Phreesia from $70.00 to $50.00 and set a “market outperform” rating for the company in a research report on Thursday, March 31st. SVB Leerink dropped their target price on shares of Phreesia from $41.00 to $29.00 and set a “market perform” rating on the stock in a report on Thursday, March 31st. Needham & Company LLC decreased their target price on shares of Phreesia from $65.00 to $35.00 and set a “buy” rating for the company in a research note on Thursday, March 31st. Canaccord Genuity Group lowered their price objective on Phreesia from $81.00 to $49.00 in a research report on Thursday, March 31st. Finally, Raymond James decreased their price objective on Phreesia from $55.00 to $45.00 and set an “outperform” rating on the stock in a report on Friday, April 1st. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $50.31.
In related news, CFO Randy Rasmussen sold 2,228 shares of the company’s stock in a transaction on Wednesday, January 19th. The stock was sold at an average price of $32.66, for a total transaction of $72,766.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 5.60% of the company’s stock.
Large investors have recently made changes to their positions in the business. UBS Group AG grew its holdings in shares of Phreesia by 4.9% during the third quarter. UBS Group AG now owns 3,350 shares of the company’s stock valued at $207,000 after buying an additional 155 shares in the last quarter. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Phreesia by 3.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 6,935 shares of the company’s stock valued at $428,000 after purchasing an additional 201 shares during the period. Arizona State Retirement System lifted its position in shares of Phreesia by 2.4% in the third quarter. Arizona State Retirement System now owns 12,378 shares of the company’s stock worth $764,000 after purchasing an additional 293 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its holdings in shares of Phreesia by 18.6% during the third quarter. O Shaughnessy Asset Management LLC now owns 2,121 shares of the company’s stock worth $131,000 after purchasing an additional 332 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in Phreesia by 23.0% during the third quarter. Nisa Investment Advisors LLC now owns 2,140 shares of the company’s stock valued at $132,000 after purchasing an additional 400 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.
The company has a quick ratio of 7.15, a current ratio of 5.65 and a debt-to-equity ratio of 0.02. The stock’s 50 day moving average price is $29.15 and its two-hundred day moving average price is $45.54. The firm has a market capitalization of $1.41 billion, a price-to-earnings ratio of -11.75 and a beta of 1.36.
Phreesia (NYSE:PHR – Get Rating) last announced its quarterly earnings results on Wednesday, March 30th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.03) by $0.33. Phreesia had a negative return on equity of 25.34% and a negative net margin of 55.41%. The business had revenue of $58.02 million during the quarter, compared to analyst estimates of $56.34 million. During the same period in the previous year, the company earned ($0.18) EPS. The firm’s revenue was up 38.8% on a year-over-year basis. On average, equities analysts expect that Phreesia, Inc. will post -3.95 EPS for the current fiscal year.
Phreesia Company Profile (NYSE:PHR)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.